PARTNER NEWS:Fri, May 3, 7:57 AM, Zacks
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Kymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the current cash balance to provide a runway into the first half of 2027.
Wed, May 1, 10:35 AM, Zacks
Amarin's (AMRN) Q1 Earnings and Revenues Surpass Estimates
Amarin (AMRN) posts better-than-expected first-quarter 2024 results. Vascepa's sales in the United States continue to be hurt by generic competition.